Salivary and crevicular fluid interleukins in gingivitis by Boronat Catalá, Montserrat et al.
e175
J Clin Exp Dent. 2014;6(2):e175-9. Interleukins in gingivitis
Journal section: Oral Medicine and Pathology
Publication Types: Review
Salivary and crevicular fluid interleukins in gingivitis 
Montserrat Boronat-Catalá 1, Montserrat Catalá-Pizarro 2, Jose V. Bagan  3
1 Graduate in Dentistry
2  Full Professor of Pediatric Dentistry at the University of Valencia
3 Full Professor of Oral Medicine at the University of Valencia
Correspondence:
Facultad de Medicina y Odontología
Universidad de Valencia
C/ Gascó Oliag 1
46010, Valencia, España
montserrat.catala@uv.es
Received: 01/12/2013
Accepted: 23/12/2013
Abstract 
Introduction: Gingivitis is a frequent inflammatory process of the gum tissue that is mainly caused by the accumu-
lation of plaque. The immune response against inflammatory processes is regulated in part by cytokines. 
Aims: Given that a continuous inflammation exists in gingivitis, it would be logical to assume that the interleukins 
will be altered locally in those patients. Therefore, the aim of this review was to check whether there is evidence 
that the interleukins can be used as diagnostic markers of inflammation levels in patients with gingivitis.  
Materials and Methods: A bibliographical search was undertaken using the key words interleukin and gingivitis in 
Pubmed, Cochrane, Scopus and Embase. Only those articles published over the last 10 years that were systematic 
reviews, case-controls or cohort studies in which interleukins in saliva and/or crevicular fluid was investigated in 
patients with gingivitis were selected. 
Results: Finally 15 articles were selected, all of them being case-control studies. The interleukins analyzed in the 
reviewed articles were: IL-1β, IL-8, IL-18, IL-11, IL-12, TNFα, IL-4, IL-17, IL-1α and IL-6. The most commonly 
studied interleukin is IL-1β and most authors agree that it is higher in the saliva and/or crevicular fluid of patients 
with gingivitis. Therefore, it could be used as a diagnostic marker of the degree of inflammation in gingivitis. Mo-
reover, as far as the other interleukins studied are concerned, there is no clear consensus among the authors.  
Conclusion: There is sufficient evidence to suggest that IL-1β in saliva and/or crevicular fluid can be used as a 
marker of the degree of inflammation in gingivitis.
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Introduction
Gingivitis or inflammation of the gum tissue is of a wide 
ranging etiology in which local factors intervene such 
as dental plaque, calculus (tartar), food impaction,  irri-
tation from restorations, etc. and several systematic fac-
tors such as pregnancy, diabetes, nutritional alterations, 
etc. (1)
The most common form of gingivitis is that caused by 
bacterial plaque, which is the inflammation of gum tis-
sue as a result of the bacteria located on the gingival 
margin (2). The relationship between bacterial plaque 
and gingival inflammation has frequently been postula-
ted as the cause of gingivitis and its role in the etiology 
has been confirmed in experimental gingivitis studies on 
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Results
- Data on the articles selected
All the articles selected were case-control studies. The 
oldest article was from 2003 and the most recent from 
2013. The articles came from 8 different countries mostly 
from Turkey, India and the United Kingdom. Most arti-
cles were obtained from the Journal of Periodontal Re-
search, the Journal of Periodontology and the Journal of 
Clinical Periodontology. Finally, the mean impact factor 
of the journals from which the articles came was 2.243. 
(Fig. 1)
human beings (3).
The immune system is the barrier against infectious mi-
croorganisms that affect the oral cavity (4). The complex 
network of cytokines that intervene in the immune res-
ponse of the host against external attacks include pro-
inflammatory cytokines, anti-inflammatory cytokines 
and receptor cells for these cytokines (5).
Interleukins are cytokines which play an important role 
in communication between inflammatory cells following 
the activation of the immune system (6). It would, the-
refore, be of great interest to know which of them act as 
mediators in gingival inflammation.
In gingivitis there is a build up of bacteria that causes 
inflammation of the gum tissue and, therefore, triggers 
the innate immunological response, an abundant series 
of macrophage cells, in turn, producing interleukins. If 
there is continuous inflammation in the gingivitis, it is 
understood that the interleukins will be altered in pa-
tients with this pathology.
The main aim, therefore, of this review was to find out 
from the literature available the degree to which inter-
leukins can be used as diagnostic markers of the degree 
of inflammation in gingivitis.
The specific objectives were:
1. To establish which interleukins show a diagnostic co-
rrelation with gingivitis.  
2. To show the degrees of scientific evidence and their 
grades of recommendation, following the criteria of 
the Oxford Centre for Evidence-Based Medicine Le-
vels of Evidence 2010, for the various interleukins 
analyzed.
Material and Methods
A bibliographical search was undertaken using the key 
words: “interleukin and gingivitis” in Pubmed, the cut-
off point for that search being articles published over the 
last 10 years. This was then supplemented by a search 
using the same key words in the following databases: 
Cochrane, Scopus and Embase.
The inclusion criteria for selecting articles were as fo-
llows:
1. Articles had to be systematic reviews, case-control 
studies or cohort studies.
2. The articles had to study interleukins in saliva and/or 
crevicular fluid in humans.
3. The samples had to be made up of individuals with 
gingivitis.
Finally 15 articles were selected that were then analyzed 
from the perspective of variables such as: the interleukin 
analyzed, the type of study, the laboratory method, the 
sample, the type of patient selection, the results, the le-
vel of evidence and grade of recommendation for each 
article.
Fig. 1. Impact factor of analyzed articles.
The total number of patients included in the samples 
from all the articles amounted to 743, with a mean age 
of 32.70 years. The percentages per gender of the total 
sample were 43.92% for males and 56.08% for females.
- Data on findings in interleukins
The relationship of interleukins in saliva and crevicu-
lar fluid with gingivitis was initially analyzed in 2003 
by Faizuddin et al. (7), who undertook a case-control 
study in which IL-1β in the crevicular fluid of patients 
was analyzed. In this study their results showed that the 
levels of IL-1β in the crevicular fluid of patients with 
periodontitis were higher than those in patients with 
gingivitis and also that the levels of this interleukin in 
gingivitis and periodontitis were much higher than in 
healthy patients.
Tsai et al. in 2005 (8), after carrying out a case-control 
study in which they analyzed interleukins 12 and 16, 
found that  IL-16 was higher in the crevicular fluid of 
healthy patients, followed by those with gingivitis and 
periodontitis. They also found that the total concentra-
tion of IL-12 was significantly higher in the crevicular 
fluid of patients affected by gingivitis and periodontitis 
than in healthy patients.
Deinzer et al. (9), in the year 2007, published a case-
control study which compared a group of gingivitis pa-
tients with another of experimental gingivitis. Outstan-
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ding among their results were that the individuals who 
were subject to experimental gingivitis presented higher 
IL-1β and lower IL-8 levels at 4 weeks than individuals 
with persistent gingivitis.
Yücel et al. (5), in 2008, found, in a case-control study 
of patients with gingivitis and patients with periodonti-
tis, that the amount of  IL-11 and IL-1β was higher in 
the gingivitis group than in the control group. They also 
found that IL-12 was higher in the group with chronic 
periodontitis.
That same year Ülker et al. (10) published a case-control 
study consisting of a group of children in which they 
found that in non-stimulated total saliva, TNFα was hig-
her in healthy children and IL-1β  higher in children with 
gingivitis. Lastly Pradeep et al. (6), in their case-control 
study, found that the highest concentration of IL-4 was 
in the control group, the lowest in the group with perio-
dontitis, and the group with gingivitis had intermediate 
concentrations of this interleukin.
In 2009 Türkoglu et al. (4), in a case-control study, 
analyzed IL-18 in the crevicular fluid of patients with 
periodontitis and gingivitis, but found no differences in 
the levels of this interleukin in the different study groups. 
In 2009 Pradeep et al. (11) also published a case-control 
study in which they found that the lowest levels of IL-18 
were in the control group patients and the highest levels 
in patients with periodontitis, with intermediate concen-
trations of this interleukin in the gingivitis group, and 
that the levels of IL-17 were imperceptible in all study 
groups. In a later publication by Pradeep et al. (12) the 
outstanding result obtained was that IL-18 was higher 
in the crevicular fluid of patients with periodontitis and 
had a positive correlation with the seriousness of the di-
sease.
Offenbacher et al. (13), in 2010, in their case-control 
study found that in experimental gingivitis, IL-1β and 
IL1α increased, while IL-8 decreased. In the same year, 
Trombelli et al. (14) found, after undertaking a case-
control study on experimental gingivitis, that IL-1β in 
experimental gingivitis was greater than under normal 
conditions. Perozini et al. (15) analyzed IL-1β in another 
case-control study and found that it was highest in the 
periodontitis group, but found no differences between 
the gingivitis and control group.
Scott et al. in 2012 (16) carried out a case-control study 
in which they also analyzed IL-1β in patients with ex-
perimental gingivitis and found that this interleukin in-
creased during experimental gingivitis and then returned 
to initial levels following the return to normal hygiene. 
Again in 2012 Becerik et al. (17) published a case-con-
trol study in which they obtained results showing that 
the levels of IL-1β and IL-6 in patients with gingivitis 
were higher than in the control group, although these re-
sults were not statistically significant.
Finally, Ertugrul et al. (18), in 2013, conducted a case-
control study in which they found that IL-8 was higher 
in patients with gingivitis compared to the control group 
and also that there is a positive correlation between pe-
riodontal parameters and the interleukins: IL-8, IL-1β 
and TNFα (Table 1).
- The articles’ level of evidence and grade of recommen-
dation
Following the criteria of the Oxford Centre for Eviden-
ce-Based Medicine Levels of Evidence 2010, all the ar-
ticles reviewed are case-control studies and correspond 
to the level of evidence IIIb and a B grade of recommen-
dation.
Discussion
Having reviewed the literature, we can confirm that IL-
1b is the most commonly studied interleukin by authors 
who have tried to establish inflammation markers in gin-
givitis. Ten studies have investigated this interleukin, all 
of them being case-control studies and all analyzing IL-
1b in crevicular fluid using the ELISA technique. Some 
of these studies (9,13,14,16) analyze this interleukin in 
experimental gingivitis and all found that it is higher in 
the crevicular fluid of patients with experimental gingi-
vitis and that the levels of this interleukin return to nor-
mality following the clinical resolution of the gingivitis 
(13,16). Three of the studies analyzed this interleukin 
(5,7,10) in non-experimental gingivitis, the authors fin-
ding that  IL-1b was higher in patients with gingivitis 
when compared to those of the control group and that 
these results were statistically significant. However, in 
other studies where the results showed that IL-1b was 
higher in the crevicular fluid of patients with gingivi-
tis, the results were not statistically significant (15,17). 
Lastly, as far as findings on IL-1b are concerned, one 
of the studies published only found a positive correla-
tion between the clinical periodontal parameters and the 
amount of interleukin in crevicular fluid (18). Therefore, 
the majority of the studies that have analyzed IL-1b in 
saliva and/or the crevicular fluid of patients with gingi-
vitis are in agreement that this interleukin is a reliable 
marker of the level of inflammation in gingivitis.
IL-8 is analyzed in three of the studies reviewed 
(9,13,18). All of these are case-control studies and use 
the ELISA technique to measure the interleukins. In two 
of them (9,13) levels of IL-8 in experimental gingivi-
tis are analyzed and both studies observe a decrease in 
this interleukin in the crevicular fluid of patients with 
experimental gingivitis. However, the authors explain 
that their results appear contradictory and that this may 
be due to the study not being undertaken over a suffi-
ciently long period of time (9), whereas others conclude 
that inducing gingivitis is related with the suppression of 
several cytokines such as IL-8 (13). Contrary to these re-
sults, there is one study that claims that IL-8 is higher in 
the crevicular fluid of patients with gingivitis (18). The 
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results found on  IL-8 are, therefore, contradictory and 
do not allow us to classify this interleukin as a marker of 
inflammation in gingivitis, given that more studies are 
required to analyze this interleukin in naturally occu-
rring gingivitis rather than in experimental gingivitis.
Three of the case-control studies analyze IL-18 (4,11,12), 
employing the ELISA technique. Two of these publica-
tions (11,12) coincide in finding a lower amount of IL-
18 in the control group and a higher amount in the pe-
riodontitis group, with intermediate levels for gingivitis. 
However, the study of Turkoglu et al. (4) did not find any 
differences in the level of this interleukin in the different 
study groups. There is, therefore, no clear consensus on 
the usefulness of IL-18 as an inflammation marker in 
gingivitis.
IL-11 was analyzed in two case-control studies in patients 
with gingivitis (5,17) using the ELISA technique. Whe-
reas in one of them the authors found a greater amount 
of IL-11 in the crevicular fluid of patients with gingivitis 
(5), in the other, they only found a higher amount of this 
interleukin in the crevicular fluid of patients with perio-
dontitis (17), so more studies are required to analyze this 
interleukin as, at the moment, there is no clear consensus 
in terms of its relationship with gingivitis. 
Two authors analyzed IL-12 (5,8) in their case-control 
studies and there is no clear consensus between them, 
as in one study they found a greater amount of IL-12 in 
gingivitis and periodontitis than in the control group (8), 
whereas in the other they only found this interleukin to 
be related with periodontitis (5).
TNFα is studied in two of the studies analyzed, both be-
ing case-control studies and using the ELISA technique 
to measure the interleukins. Outstanding among the re-
sults is that in one of these studies it was found that in 
non-stimulated saliva TNFα was higher in the control 
group, even though these results were not statistically 
significant (10). This study also found that TNFα in cre-
vicular fluid was greater in patients with gingivitis than 
AUTHOR, YEAR SAMPLE PATHOLOGY TECNIQUE RESULTS
Faizuddin et al.
(2003)
60 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-1β higher in Periodontitis and Gingivitis than in con-
trol.
Tsai et al.
 (2005)
25 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-12 higher in Chronic Periodontitis and Gingivitis than 
in control. Higher in Chronic Periodontitis than in Gingi-
vitis.
Deinzer et al.
 (2007)
26 Gingivitis & Experi-
mental gingivitis
ELISA Crevi-
cular fluid
In Experimental gingivitis higher IL-1β and lower IL-8 
than in Gingivitis.  
Yucel et al.
 (2008)
40 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-11 lower in Chronic Periodontitis than in Gingivitis and 
Controls and higher in Gingivitis than in Controls.
IL-12 and IL-1β higher in Periodontitis than in Controls.
Ülker et al.
(2008)
35 Gingivitis ELISA Saliva 
and Crevicular 
fluid
Saliva: TNFα higher in controls, IL-1β higher in Gingivi-
tis.
Crevicular F.: TNFα and IL-1β higher in  Gingivitis
Pradeep et al.
 (2008)
60 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-4 higher in control and lower in Periodontitis, interme-
diate in Gingivitis and post-treatment Periodontitis.
Türkoglu et al.
 (2009)
59 Gingivitis & chronic 
periodontitis
ELISA Crevi-
cular fluid
No differences found in the levels of IL-18 in the study 
groups.
Pradeep et al.
(2009)
60 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-18 lower in controls and higher in Periodontitis, in-
termediate in Gingivitis. Reduced following periodontal 
treatment. Undetectable IL-17.
Pradeep et al.
 (2009)
60 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-18 higher in Periodontitis. Positive correlation with se-
riousness.
Offenbacher et al.
 (2010)
25 Experimental gin-
givitis
ELISA Crev-
icular fluid
IL-1β and IL-1α higher in Experimental gingivitis. IL-8 
lower in Experimental gingivitis.
Trombelli et al.
 (2010)
37 Experimental gin-
givitis
ELISA Crev-
icular fluid
IL-1β higher in Experimental gingivitis.
Perozini et al.
 (2010)
36 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-1β higher in Periodontitis. Positive correlation between 
IL-1β , volume of Crevicular Fluid and probe depth 
Scott et al.
 (2012)
56 Experimental gin-
givitis
ELISA Crev-
icular fluid
IL-1β increases in Experimental gingivitis.
Beceriket al.
(2012)
60 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-1β, IL-6 e IL-11 higher in Chronic and Aggressive Pe-
riodontitis.
Ertugrul et al.
 (2013)
84 Gingivitis & perio-
dontitis
ELISA Crev-
icular fluid
IL-1β, TNFα e IL-8 lower in control and higher in Aggres-
sive Periodontitis.
IL-8 higher in Gingivitis than in Controls.
Correlation +between IL-1β, TNFα and IL-8 and periodon-
tal parameters.
Table 1. Data on findings in interleukins.
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in the control group (10). Nevertheless, in another publi-
cation, the authors only found a positive correlation bet-
ween the periodontal parameters and TNFα. These two 
results are difficult to compare as the ages of the samples 
differ widely and this could affect the results. Therefore, 
in order to be able to discover whether there is a rela-
tionship between TNFα and inflammation in gingivitis 
further studies are required with groups of similar ages. 
Finally, four of the interleukins reviewed are analyzed 
separately in four different articles and the results the 
authors found for each one were as followed: IL-4 was 
found to be highest in the control group and lowest in the 
periodontitis group, with intermediate levels for gingivi-
tis (6). IL-17 was found to be almost imperceptible in all 
study groups (11). IL-1α was found to be higher in the 
crevicular fluid of patients who had been subject to ex-
perimental gingivitis (13). Finally, for IL-6, the authors 
found that in the gingivitis group, IL-6 was higher, but 
the results were not statistically significant (17).
Conclusions
Following our analysis of the results of the studies, we 
can establish the following conclusions: 
Firstly, of all the interleukins studied to date in crevi-
cular fluid and/or the saliva of patients with gingivitis, 
IL-1b has been the most analyzed and that the majority 
of authors (70%) that have investigated it in their studies 
agree that it is higher in situations of gingivitis and ex-
perimental gingivitis. All these studies are comparable 
as they are case-control studies and the interleukins are 
measured using the same technique. Therefore, we can 
conclude that IL-1b can be used as a diagnostic marker 
of inflammation in patients with gingivitis.
Secondly, as far as the other interleukins studied are con-
cerned: IL-12, IL-8, IL-11, IL-4, TNFa, IL-18, IL-17, 
IL-1a, and IL-6, we have not found a consensus among 
the authors and their results do not coincide sufficiently 
so as to classify them as diagnostic markers of degrees 
of inflammation. 
Lastly, as the level of evidence of all the articles re-
viewed in undertaking this work according to the Oxford 
Centre for Evidence-Based Medicine Levels of evidence 
2010 is IIIb and the degree of recommendation of the 
same is B, we can say that the evidence on using IL-1b 
in saliva and/or crevicular fluid as a marker of the degree 
of inflammation in gingivitis is conclusive.
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